FDA Announces Draft Guidance for Prescription Blood Glucose Monitoring Test Systems

Summary

The Food and Drug Administration (FDA) has released a draft guidance document outlining studies and criteria for blood glucose monitoring test systems intended for prescription point-of-care use, with the goal of guiding manufacturers in preparing premarket notifications.